Shirley Kuan
Adult Health · Bridgeport, CTNPI 1255938940
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 260 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 30.8% of the total. Reporting peaked in 2023 at $3,418 and has fallen 99.5% since, to $19 in 2025. Among adult health clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 260 payments — averaging $21.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$825
- Novo Nordisk$508
- Pfizer$342
- Viiv Healthcare Company$329
- Gilead$240
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,625100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 81 | $1,734 |
| AstraZeneca | 35 | $825 |
| Novo Nordisk | 27 | $508 |
| Pfizer | 17 | $342 |
| Viiv Healthcare Company | 10 | $329 |
| Gilead | 11 | $240 |
| GSK | 10 | $226 |
| Amgen | 6 | $226 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $174 |
| Exact Sciences | 10 | $173 |
| Boehringer Ingelheim | 13 | $169 |
| Ironwood Pharmaceuticals, Inc | 8 | $145 |
| Merck | 4 | $128 |
| Ardelyx, Inc. | 4 | $85 |
| Lundbeck LLC | 3 | $61 |
| Lilly USA, LLC | 2 | $51 |
| Johnson & Johnson | 1 | $37 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Phadia US Inc. | 2 | $34 |
| Bayer | 1 | $30 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Cequr Corporation | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,625 in reported general payments places this provider in the 90th percentile of 418 adult health providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 32 | $33,476 |
| JardianceEmpagliflozin | 22 | $21,890 |
| OzempicSemaglutide | 13 | $12,574 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $11,437 |
| TradjentaLinagliptin | 13 | $10,542 |
| SymbicortBudesonide/Formoterol Fumarate | 20 | $6,470 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 75 | $1,712 |
| Ventolin HfaAlbuterol Sulfate | 28 | $1,605 |
| Comfort Ez Pen NeedlePen Needle, Diabetic | 11 | $1,254 |
| Alcohol Prep PadsAlcohol Antiseptic Pads | 17 | $788 |
| Atorvastatin Calcium | 90 | $742 |
| Famotidine | 38 | $648 |
| Fluticasone Propionate | 35 | $517 |
| Rosuvastatin Calcium | 35 | $480 |
| Metoprolol Succinate | 33 | $461 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $825 | $51,38471 claims |
| Boehringer IngelheimJardiance, Tradjenta | $169 | $32,43235 claims |
| Novo NordiskOzempic | $508 | $12,57413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 418 adult health providers in Connecticut.
Other adult health in Bridgeport
- Deanne RendockBridgeport$14K
- Wendy AwaBridgeport$5K
- Leah EhleManchester$418K
- Laura MulkaWethersfield$306K
- Gretchen MichaelsonSouth Windsor$169K
- Kimberly RyanWethersfield$74K
- Kathryn JackMeriden$67K
- Lynn RapsilberTorrington$52K
- Genice NelsonFarmington$36K
- Andrea LauterNew London$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.